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Abstract 
 
Introduction: Measurement of small solute clearance is the objective means of quantifying dose 
of peritoneal dialysis (PD) and various organisations have issued guidelines on target values. 
Assessment of PD adequacy involves other factors such as blood pressure control, anaemia 
management, mineral metabolism, nutritional status and ultrafiltration. Membrane transport 
characteristic is important for PD prescription on an individual patient basis and is related to 
patient outcome. In this study the adequacy of PD, using small solute clearance measurement as 
well as other factors, and membrane characteristics have been assessed and classification of 
patients using our own reference values is reported for the first time. Nutritional status has been 
studied and the use of simple tools such as the subjective global assessment has been validated 
for use in our patients.   
Materials and Methods:  A cross sectional study involving 80 adult continuous ambulatory 
peritoneal dialysis (CAPD) patients. Peritoneal equilibration test (PET) was performed to assess 
the membrane characteristics; 24 hour dialysate fluid and urine samples were collected and used 
for the measurement of solute clearance, while nutritional status was assessed using the 
subjective global assessment (SGA) instrument, anthropometric measurements and serum 
albumin estimation.   
Results: The mean age was 38 ± 12.43 years, 42.3% were females and 86% were blacks.  Mean 
duration on CAPD was 19.8 ± 20.67 months. The mean of 4 hour D/P creatinine was 0.74 ± 0.13 
and based on this, 18% were high transporters, 33.8% high average, 36.9% low average and 12% 
low transporters. Mean kt/v urea was 1.72± 0.32, and the recommended level of 1.7 was 
achieved by 62.8% of the patients. Mean haemoglobin was 10.99 ± 2.14 g/dl  and the 
recommended target value of 11-12g/dl was reached by 55.8% of the patients. The mean BMI 
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was 24.76 ± 3.50, mean Mid Upper Arm Circumference (MUAC) was 28.53±3.89 cm and mean 
serum albumin was 37.10 ± 7.6 g/l. Based on SGA scores, 42% of our patients were well 
nourished, 50% moderately undernourished while 8% were severely malnourished. We noted 
significant correlations between SGA score and BMI and MUAC while there was none with 
serum albumin level. The mean serum calcium and phosphate levels were within normal though 
the mean PTH level was higher. 
Conclusion: The D/P creatinine at 4 hours was higher than those reported in the literature, 
though the distribution of the transport types was similar. The recommended targets of kt/v and  
haemoglobin were achieved by the majority of our patients. Mineral metabolism parameters 
were within normal range.  Malnutrition is common and SGA is a reliable method for nutritional 
assessment in our patients.   
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